No Action as Yet on Rimonabant in Europe

The European drug regulatory authority has decided to continue to review safety data on rimonabant and discuss it again next month. Separately, Sanofi has failed in its appeal for the drug to be reimbursed in Germany. Sue Hughes

Continue to No Action as Yet on Rimonabant in Europe on Medscape Medical News Headlines.

Medical Buzz delivers the most recent headlines from the medical world. Diseases, cures, accidents, medicin. Click below for more headlines ...
Medical buzz